Fagron is a pharmaceutical compounding company based in Belgium. It supplies pharmacies, hospitals and clinics with the ingredients, excipients and equipment needed to prepare custom-made medicines, along with ready-to-use compounding products and related services. Its customers include community pharmacists, hospital pharmacies and other healthcare providers, and it operates across Europe, the Americas and other regions through local subsidiaries and production sites.
On this site Fagron NV appears as a stock on the Euronext Brussels (Belgium), code FAGR, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #29 of 111 on the Euronext Brussels · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Belgium yet.
TrendFair
68/100
Mixed trend against its averages.
See the numbers →
Above 200-day average2.7%
From 52-week high-7.3%
MomentumFair
61/100
Typical recent returns for this exchange.
See the numbers →
3-month return-1.3%
6-month return-0.5%
12-month, skipping last month7.2%
Stability (higher is calmer)Strong
73/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)21.2%
Worst drawdown, 1 year (smaller is calmer)-16.8%
LiquidityStrong
80/100
Trades actively.
See the numbers →
Avg daily value traded2.27M EUR
Zero-volume days0.0%
IncomeWeak
40/100
Dividend is small or irregular.
See the numbers →
Dividend yield1.7%
Years with dividends5
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Belgium when fundamentals data for this market is added. All Belgium stocks.
52-wk range 20.00 – 25.30Daily closes, split-adjusted
Signals
50-day average22.33
200-day average22.79
Golden/death cross (60d)Death, 23 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.52
Technical summary
Daily
Strongly bullish
12 bullish · 1 neutral · 3 bearish
Weekly
Strongly bullish
10 bullish · 1 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
22.93
Bullish
EMA 10
23.10
Bullish
SMA 20
22.81
Bullish
EMA 20
22.82
Bullish
SMA 50
22.33
Bullish
EMA 50
22.64
Bullish
SMA 100
22.99
Bullish
EMA 100
22.71
Bullish
SMA 200
22.79
Bullish
EMA 200
22.47
Bullish
Oscillators (daily)
RSI (14)
59.50
Neutral
MACD (12, 26)
0.30
Bullish
Momentum (12)
1.52
Bullish
Stochastic %K (14)
85.19
Bearish
Williams %R (14)
-14.81
Bearish
CCI (20)
122.8
Bearish
Pivot points (classic, last session)
S3
22.92
S2
23.13
S1
23.27
Pivot
23.48
R1
23.62
R2
23.83
R3
23.97
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.40 EUR
Yield on today's price
1.71%
Frequency
Annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
0.4000
0.3500
0.3000
0.2500
0.2000
0.1800
0.0800
0.1200
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
